Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Classement en actions #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Prix de l'action
$0.01292666
Dernière synchronisation: 2025-04-08
Capitalisation boursière
$157.54K
Changement (1 jour)
6.84%
Changement (1 an)
0.00%
Pays
GB
Échange Synairgen plc (SNG)

Catégorie

Le prix SNG avec la capitalisation boursière de B
Synairgen plc Synairgen plc
SNG
$0.01292666
Capitalisation boursière de Synairgen plc(SNG)
Capitalisation boursière: $157.54K
En August 2026, Synairgen plc a une capitalisation boursière de $157.54K. Cela fait de Synairgen plc la 40400th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Synairgen plc du 2004 au 2026
SNG par rapport au top 5 des plus populaires stocks
Prix pour SNG L’actif B La capitalisation boursière de B Résultats
Synairgen plc Synairgen plc
$448,790 $157.54K
$5.470T +3,471,815,955.71%
Synairgen plc Synairgen plc
$366,535 $157.54K
$4.467T +2,835,495,357.75%
Synairgen plc Synairgen plc
$342,519 $157.54K
$4.174T +2,649,712,215.36%
Synairgen plc Synairgen plc
$303,601 $157.54K
$3.700T +2,348,642,204.32%
Synairgen plc Synairgen plc
$234,206 $157.54K
$2.854T +1,811,807,993.27%